{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:29:28Z","timestamp":1792106968688,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ijrobp.2006.05.064","type":"journal-article","created":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T13:34:08Z","timestamp":1159536848000},"page":"714-720","source":"Crossref","is-referenced-by-count":99,"title":["Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"66","author":[{"given":"Brigette B.Y.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.M. Dennis","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.Y.","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin P.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sing F.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frankie","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing H.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2006.05.064_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","article-title":"Epstein-Barr virus in the pathogenesis of NPC","volume":"12","author":"Raab-Traub","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib3","first-page":"1188","article-title":"Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma","volume":"59","author":"Lo","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2004.05.178","article-title":"A phase II study of neoadjuvant taxol and carboplatin followed by concurrent cisplatin-radiotherapy in locoregionally advanced nasopharyngeal carcinoma with EBV DNA monitoring","volume":"22","author":"Chan","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2000.tb06597.x","article-title":"Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma","volume":"906","author":"Lo","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib6","first-page":"6878","article-title":"Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA","volume":"60","author":"Lo","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib7","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","article-title":"Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma","volume":"94","author":"Chan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1373\/clinchem.2005.054783","article-title":"Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma","volume":"51","author":"Chan","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000055764","article-title":"[Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck","volume":"63","author":"Jacob","year":"2001","journal-title":"J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.20.2.379","article-title":"Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography","volume":"20","author":"Bos","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ijc.20057","article-title":"Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary","volume":"109","author":"Kurokawa","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib12","first-page":"3837","article-title":"Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography","volume":"6","author":"Vesselle","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib13","first-page":"1279","article-title":"(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma","volume":"6","author":"Folpe","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ygyno.2005.09.030","article-title":"FDG-PET in the detection of recurrence of uterine cervical carcinoma after radiation therapy-tumor volume and FDG uptake value","volume":"100","author":"Sakurai","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2006.05.064_bib15","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1007\/s00259-004-1529-6","article-title":"Biological characterisation of breast cancer by means of PET","volume":"31","author":"Buck","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular imaging of cancer with positron emission tomography","volume":"2","author":"Gambhir","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib17","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1200\/JCO.1998.16.11.3550","article-title":"Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography","volume":"16","author":"Kao","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00432-002-0341-6","article-title":"Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy","volume":"128","author":"Tsai","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib19","first-page":"770","article-title":"Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma","volume":"46","author":"Yen","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.2311030271","article-title":"Head and neck cancer: Clinical usefulness and accuracy of PET\/CT image fusion","volume":"231","author":"Schoder","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/snuc.2003.127312","article-title":"Applications of positron emission tomography\/computed tomography image fusion in clinical positron emission tomography\u2014clinical use, interpretation methods, diagnostic improvements","volume":"33","author":"Cohade","year":"2003","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib22","series-title":"Cancer staging handbook","year":"2002"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1259\/bjr.72.860.10624338","article-title":"MRI of local disease in nasopharyngeal carcinoma: Tumour extent vs tumour stage","volume":"72","author":"King","year":"1999","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0347(200005)22:3<275::AID-HED10>3.0.CO;2-N","article-title":"Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease","volume":"22","author":"King","year":"2000","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib25","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1200\/JCO.2004.08.120","article-title":"Accuracy of whole-body dual-modality fluorine-18\u20132-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET\/CT) for tumor staging in solid tumors: Comparison with CT and PET","volume":"22","author":"Antoch","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib26","first-page":"283","article-title":"Application of intravenous contrast in PET\/CT: Does it really introduce significant attenuation correction error?","volume":"46","author":"Yau","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib27","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2005.23.16_suppl.5544","article-title":"A randomized phase II study of concurrent cisplatin-radiotherapy (RT) with or without neoadjuvant chemotherapy using docetaxel (Taxotere) and cisplatin in advanced nasopharyngeal carcinoma (NPC)","author":"Chan","year":"2005","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/clinchem\/48.8.1186","article-title":"Plasma nucleic acids in the diagnosis and management of malignant disease","volume":"48","author":"Johnson","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib29","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1373\/clinchem.2004.036640","article-title":"Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma","volume":"50","author":"Lit","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib30","first-page":"2028","article-title":"Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients","volume":"63","author":"Chan","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0360-3016(97)00374-X","article-title":"Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome","volume":"39","author":"Chua","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.10.027","article-title":"Primary tumor volume of nasopharyngeal carcinoma: Prognostic significance for local control","volume":"59","author":"Sze","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3349\/ymj.2005.46.2.221","article-title":"Prognostic value of tumor volume in nasopharyngeal carcinoma","volume":"46","author":"Kim","year":"2005","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/radiol.2331030660","article-title":"Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison of CT, MR imaging, and FDG PET and validation with surgical specimen","volume":"233","author":"Daisne","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0360-3016(97)00465-3","article-title":"The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer","volume":"39","author":"Rasch","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib36","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/excr.2000.4834","article-title":"Apoptotic DNA fragmentation","volume":"256","author":"Nagata","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib38","first-page":"658","article-title":"Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis","volume":"46","author":"Yagle","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib39","first-page":"3315","article-title":"In vivo validation of 3\u2032deoxy-3\u2032-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: Correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors","volume":"8","author":"Vesselle","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib40","first-page":"405","article-title":"The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx","volume":"46","author":"Yen","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00259-004-1719-2","article-title":"Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?","volume":"32","author":"Yen","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2006.05.064_bib42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cncr.11496","article-title":"Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type","volume":"98","author":"Leung","year":"2003","journal-title":"Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606009837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606009837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T10:49:58Z","timestamp":1587206998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301606009837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0360301606009837"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2006.05.064","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}